Suzanne Vanbenthuysen, MD
Pediatrics · Austin, TXNPI 1962673301
Payments from drug & device makers
Across 36 payments — averaging $16.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cranial Technologies, Inc$184
- Merck$78
- Sanofi Pasteur Inc.$66
- GSK$44
- Ironshore Pharmaceuticals Inc.$37
- Supernus Pharmaceuticals, Inc.$37
- plus $160 from 8 others
What the payments were for
- Food & beverage$607100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cranial Technologies, Inc | 12 | $184 |
| Merck | 4 | $78 |
| Sanofi Pasteur Inc. | 3 | $66 |
| GSK | 3 | $44 |
| Ironshore Pharmaceuticals Inc. | 2 | $37 |
| Supernus Pharmaceuticals, Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Genentech USA, Inc. | 2 | $29 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $25 |
| Neos Therapeutics, LP | 1 | $19 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| Tris Pharma Inc | 1 | $14 |
| Sobi, Inc | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$607 in reported general payments places this provider in the 70th percentile of 5,361 pediatrics providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $278 |
| Cephalexin | 12 | $65 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Austin
- Jacques BenunAustin$1.3M
- Kashif AliHouston$19.1M
- Clifford YutThe Woodlands$10.2M
- Ionela IacobasHouston$10.1M
- Khozema PalanpurwalaHouston$9.7M
- Robert BellBeaumont$9.3M
- John ClintonPort Lavaca$8.6M
- Ronald BlairDallas$7.7M
- Wieslaw JakubowskiCorpus Christi$5M
- Martin YudovichHouston$4.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.